Entyvio FDA Approval History
FDA Approved: Yes (First approved May 20, 2014)
Brand name: Entyvio
Generic name: vedolizumab
Dosage form: Injection
Company: Takeda Pharmaceutical Company Limited
Treatment for: Crohn's Disease, Acute, Ulcerative Colitis
Entyvio (vedolizumab) is an integrin receptor antagonist for the treatment of Crohn's disease and ulcerative colitis.
Development timeline for Entyvio
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.